BioGend Therapeutics Co., Ltd.(TW:6733)
NT$20.85-0.15 (-0.71%)
TW:6733
BioGend Therapeutics Co., Ltd. earnings date
NT$20.85
At close:-0.15 (-0.71%)
BioGend Therapeutics Co., Ltd. (6733) Earnings Dates, Call Summary & Reports
Earnings Data
- Estimated Report Date
- Mar 02, 2027
- Period Ending
- 2026 (Q4)
- Consensus EPS Forecast
- ―
- Last Year’s EPS
- -0.18
TBA (Not Confirmed)
Same Quarter Last Year
BioGend Therapeutics Co., Ltd. (TW:6733) Earnings, Revenues Date & History
The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced.
TW:6733 Q3 2026 Earnings Report
TW:6733 Upcoming Earnings
BioGend Therapeutics Co., Ltd.'s next earnings date is estimated for March 2, 2027, based on past reporting schedules.
TW:6733 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release | Slides | Play Transcript |
|---|---|---|---|---|---|---|---|
| Mar 02, 2027 | 2026 (Q4) | ―- | -0.18 | ― | ― | ― | ― |
| Nov 05, 2026 | 2026 (Q3) | ―-0.17 | -0.06 | -198.21% (-0.11) | ― | ― | |
| May 06, 2026 | 2026 (Q1) | -0.13-0.13 | -0.27 | 52.06% (+0.14) | ― | ― | |
| Feb 24, 2026 | 2025 (Q4) | -0.10-0.18 | -0.32 | 43.40% (+0.14) | ― | ― | |
| Nov 06, 2025 | 2025 (Q3) | -0.09-0.06 | -0.25 | 77.51% (+0.19) | ― | ― | |
| Aug 07, 2025 | 2025 (Q2) | -0.18-0.19 | -0.28 | 32.26% (+0.09) | ― | ― | |
| May 07, 2025 | 2025 (Q1) | -0.16-0.27 | -0.09 | -196.67% (-0.18) | ― | ― | |
| Feb 25, 2025 | 2024 (Q4) | -0.23-0.32 | -0.26 | -20.91% (-0.06) | ― | ― | |
| Nov 08, 2024 | 2024 (Q3) | -0.25-0.25 | -0.36 | 30.64% (+0.11) | ― | ― | |
| Aug 08, 2024 | 2024 (Q2) | -0.28-0.28 | -0.26 | -9.41% (-0.02) | ― | ― |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous quarter.
Beat Missed
TW:6733 Earnings-Related Price Changes
| Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Nov 05, 2026 | NT$21.50 | NT$21.00 | -2.33% |
| May 06, 2026 | NT$28.50 | NT$29.00 | +1.75% |
| Feb 24, 2026 | NT$37.65 | NT$36.75 | -2.39% |
| Nov 06, 2025 | NT$41.22 | NT$39.83 | -3.39% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after its recent earnings reports.
FAQ
When does BioGend Therapeutics Co., Ltd. (TW:6733) report earnings?
BioGend Therapeutics Co., Ltd. (TW:6733) is estimated to report earnings on Mar 02, 2027, TBA (Not Confirmed). The date is an estimate based on past reporting schedules and may change.
